BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye Q, Wang L, Wells AD, Tao R, Han R, Davidson A, Scott ML, Hancock WW. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol. 2004;34:2750-2759. [PMID: 15368291 DOI: 10.1002/eji.200425198] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Xu H, He X, Sun J, Shi D, Zhu Y, Zhang X. The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection. Transplantation Proceedings 2009;41:112-6. [DOI: 10.1016/j.transproceed.2008.10.037] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
2 Kanagavelu S, Termini JM, Gupta S, Raffa FN, Fuller KA, Rivas Y, Philip S, Kornbluth RS, Stone GW. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS One 2014;9:e90100. [PMID: 24587225 DOI: 10.1371/journal.pone.0090100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
3 Cho B, Min C, Kim H, Lee S, Kim Y, Lim J, Jeong D, Cho B, Kim H, Eom K, Cho S, Kim D, Lee J, Min W, Kim C, Chung N. High Levels of B Cell Activating Factor During the Peritransplantation Period Are Associated with a Reduced Incidence of Acute Graft-versus-Host Disease following Myeloablative Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2010;16:629-38. [DOI: 10.1016/j.bbmt.2009.11.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
4 Chang SK, Mihalcik SA, Jelinek DF. B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation. J Immunol 2008;180:7394-403. [PMID: 18490739 DOI: 10.4049/jimmunol.180.11.7394] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
5 Rodig SJ, Shahsafaei A, Li B, Mackay CR, Dorfman DM. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders. Hum Pathol 2005;36:1113-9. [PMID: 16226112 DOI: 10.1016/j.humpath.2005.08.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
6 Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Mariño E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST. Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol 2009;182:793-801. [PMID: 19124722 DOI: 10.4049/jimmunol.182.2.793] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
7 Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol. 2005;17:282-289. [PMID: 15886118 DOI: 10.1016/j.coi.2005.04.005] [Cited by in Crossref: 251] [Cited by in F6Publishing: 231] [Article Influence: 14.8] [Reference Citation Analysis]
8 Mayne CG, Amanna IJ, Nashold FE, Hayes CE. Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur J Immunol 2008;38:587-98. [PMID: 18200501 DOI: 10.1002/eji.200737817] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
9 Nagel A, Hertl M, Eming R. B-cell-directed therapy for inflammatory skin diseases. J Invest Dermatol 2009;129:289-301. [PMID: 19148218 DOI: 10.1038/jid.2008.192] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
10 Aït-Azzouzene D, Gavin AL, Skog P, Duong B, Nemazee D. Effect of cell:cell competition and BAFF expression on peripheral B cell tolerance and B-1 cell survival in transgenic mice expressing a low level of Igkappa-reactive macroself antigen. Eur J Immunol 2006;36:985-96. [PMID: 16511898 DOI: 10.1002/eji.200535581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
11 Chang Y, Sun X, Jia X, Xu S, Wei F, Yang X, Wei W. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis. International Immunopharmacology 2015;24:451-7. [DOI: 10.1016/j.intimp.2015.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
12 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
13 Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep 2012;14:295-302. [PMID: 22535567 DOI: 10.1007/s11926-012-0258-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
14 Banham GD, Clatworthy MR. B-cell biomarkers in transplantation - from genes to therapy: B-cell biomarkers in transplantation. Tissue Antigens 2015;85:82-92. [DOI: 10.1111/tan.12520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
15 Rihacek M, Bienertova-Vasku J, Valik D, Sterba J, Pilatova K, Zdrazilova-Dubska L. B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia. Biomed Res Int 2015;2015:792187. [PMID: 26339644 DOI: 10.1155/2015/792187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
16 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Zhang M, Ko KH, Lam QL, Lo CK, Srivastava G, Zheng B, Lau YL, Lu L. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis. Int Immunol 2005;17:1081-92. [PMID: 16000326 DOI: 10.1093/intimm/dxh287] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
18 Kim KS, Park JY, Jou I, Park SM. Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia. J Leukoc Biol 2009;86:349-59. [PMID: 19406831 DOI: 10.1189/jlb.1008659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
19 Colasanti T, Spinelli FR, Barbati C, Ceccarelli F, Scarpa S, Vomero M, Alessandri C, Valesini G, Conti F. Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus. Cells 2022;11:262. [DOI: 10.3390/cells11020262] [Reference Citation Analysis]
20 Mujtaba MA, Komocsar WJ, Nantz E, Samaniego MD, Henson SL, Hague JA, Lobashevsky AL, Higgins NG, Czader M, Book BK, Anderson MD, Pescovitz MD, Taber TE. Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation. Am J Transplant 2016;16:1266-75. [PMID: 26780484 DOI: 10.1111/ajt.13557] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
21 Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity?: New genetic defects in common variable immunodeficiency. Current Opinion in Allergy & Clinical Immunology 2005;5:496-503. [DOI: 10.1097/01.all.0000191887.89773.cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
22 So T, Lee S, Croft M. Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity. International Journal of Hematology 2006;83:1-11. [DOI: 10.1532/ijh97.05120] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
23 Chong BF, Tseng LC, Kim A, Miller RT, Yancey KB, Hosler GA. Differential expression of BAFF and its receptors in discoid lupus erythematosus patients. J Dermatol Sci 2014;73:216-24. [PMID: 24315762 DOI: 10.1016/j.jdermsci.2013.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
24 Liu Y, Wang L, Predina J, Han R, Beier UH, Wang LC, Kapoor V, Bhatti TR, Akimova T, Singhal S, Brindle PK, Cole PA, Albelda SM, Hancock WW. Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity. Nat Med 2013;19:1173-7. [PMID: 23955711 DOI: 10.1038/nm.3286] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 13.3] [Reference Citation Analysis]
25 Xiao Y, Motomura S, Deyev V, Podack ER. TNF superfamily member 13, APRIL, inhibits allergic lung inflammation. Eur J Immunol 2011;41:164-71. [PMID: 21182087 DOI: 10.1002/eji.201040436] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
26 Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006;18:263-75. [PMID: 16914324 DOI: 10.1016/j.smim.2006.04.006] [Cited by in Crossref: 331] [Cited by in F6Publishing: 290] [Article Influence: 20.7] [Reference Citation Analysis]
27 Ryan MC, Grewal IS. Targeting of BAFF and APRIL for Autoimmunity and Oncology. In: Grewal IS, editor. Therapeutic Targets of the TNF Superfamily. New York: Springer; 2009. pp. 52-63. [DOI: 10.1007/978-0-387-89520-8_4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
28 Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood 2006;108:2687-94. [PMID: 16825497 DOI: 10.1182/blood-2005-12-017319] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
29 Kang JS, Yoon YD, Ahn JH, Kim SC, Kim KH, Kim HM, Moon EY. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006;141:181-8. [PMID: 16899986 DOI: 10.1159/000094897] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
30 Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Semin Immunol 2006;18:284-9. [PMID: 16931039 DOI: 10.1016/j.smim.2006.04.005] [Cited by in Crossref: 124] [Cited by in F6Publishing: 111] [Article Influence: 7.8] [Reference Citation Analysis]
31 Chen M, Lin X, Liu Y, Li Q, Deng Y, Liu Z, Brand D, Guo Z, He X, Ryffel B, Zheng SG. The function of BAFF on T helper cells in autoimmunity. Cytokine Growth Factor Rev 2014;25:301-5. [PMID: 24411564 DOI: 10.1016/j.cytogfr.2013.12.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
32 Bloom DD, Reshetylo S, Nytes C, Goodsett CT, Hematti P. Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. J Immunother 2018;41:213-23. [PMID: 29309290 DOI: 10.1097/CJI.0000000000000209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Salazar-Camarena DC, Ortíz-Lazareno P, Marín-Rosales M, Cruz A, Muñoz-Valle F, Tapia-Llanos R, Orozco-Barocio G, Machado-Contreras R, Palafox-Sánchez CA. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus. Cytokine 2019;114:115-27. [PMID: 30467093 DOI: 10.1016/j.cyto.2018.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
34 Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Front Immunol 2012;3:373. [PMID: 23248624 DOI: 10.3389/fimmu.2012.00373] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
35 Karahan GE, Claas FH, Heidt S. B Cell Immunity in Solid Organ Transplantation. Front Immunol 2016;7:686. [PMID: 28119695 DOI: 10.3389/fimmu.2016.00686] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
36 Zhao L, Tyrrell DL. Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection. Viral Immunol. 2013;26:25-39. [PMID: 23374153 DOI: 10.1089/vim.2012.0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
37 Thibault-Espitia A, Foucher Y, Danger R, Migone T, Pallier A, Castagnet S, G-Gueguen C, Devys A, C-Gautier A, Giral M. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant. 2012;12:2754-2762. [PMID: 22883025 DOI: 10.1111/j.1600-6143.2012.04194.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
38 Ding H, Wang L, Wu X, Yan J, He Y, Ni B, Gao W, Zhong X. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med 2010;14:1717-25. [PMID: 19627403 DOI: 10.1111/j.1582-4934.2009.00817.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
39 Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol. 2017;36:3-19. [PMID: 28215100 DOI: 10.1080/08830185.2016.1276903] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 12.6] [Reference Citation Analysis]
40 Clatworthy MR. B-cell regulation and its application to transplantation. Transpl Int 2014;27:117-28. [PMID: 23909582 DOI: 10.1111/tri.12160] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
41 Ota M, Duong BH, Torkamani A, Doyle CM, Gavin AL, Ota T, Nemazee D. Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol 2010;185:4128-36. [PMID: 20817867 DOI: 10.4049/jimmunol.1002176] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
42 Baek A, Park HJ, Na S, Shim DS, Moon J, Yang Y, Choi Y. The expression of BAFF in the muscles of patients with dermatomyositis. Journal of Neuroimmunology 2012;249:96-100. [DOI: 10.1016/j.jneuroim.2012.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
43 Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N. Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B. J Immunol 2008;181:2211-9. [DOI: 10.4049/jimmunol.181.3.2211] [Cited by in Crossref: 124] [Cited by in F6Publishing: 122] [Article Influence: 8.9] [Reference Citation Analysis]
44 Scapini P, Hu Y, Chu CL, Migone TS, Defranco AL, Cassatella MA, Lowell CA. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 2010;207:1757-73. [PMID: 20624892 DOI: 10.1084/jem.20100086] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
45 Groom J, Mackay F. B cells flying solo. Immunol Cell Biol 2008;86:40-6. [PMID: 18172443 DOI: 10.1038/sj.icb.7100142] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
46 Chu VT, Enghard P, Riemekasten G, Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J Immunol 2007;179:5947-57. [PMID: 17947668 DOI: 10.4049/jimmunol.179.9.5947] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
47 Vugmeyster Y, Seshasayee D, Chang W, Storn A, Howell K, Sa S, Nelson T, Martin F, Grewal I, Gilkerson E. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am J Pathol. 2006;168:476-489. [PMID: 16436662 DOI: 10.2353/ajpath.2006.050600] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
48 Gor DO, Ding X, Li Q, Sultana D, Mambula SS, Bram RJ, Greenspan NS. Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS). Biol Direct 2011;6:9. [PMID: 21306646 DOI: 10.1186/1745-6150-6-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
49 Chan CT, Sobey CG, Lieu M, Ferens D, Kett MM, Diep H, Kim HA, Krishnan SM, Lewis CV, Salimova E, Tipping P, Vinh A, Samuel CS, Peter K, Guzik TJ, Kyaw TS, Toh B, Bobik A, Drummond GR. Obligatory Role for B Cells in the Development of Angiotensin II–Dependent Hypertension. Hypertension 2015;66:1023-33. [DOI: 10.1161/hypertensionaha.115.05779] [Cited by in Crossref: 110] [Cited by in F6Publishing: 68] [Article Influence: 15.7] [Reference Citation Analysis]
50 Wang XZ, Wan Z, Xue WJ, Zheng J, Li Y, Ding CG. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study. Front Immunol 2019;10:1046. [PMID: 31156628 DOI: 10.3389/fimmu.2019.01046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
51 Jacob CO, Pricop L, Putterman C, Koss MN, Liu Y, Kollaros M, Bixler SA, Ambrose CM, Scott ML, Stohl W. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 2006;177:2671-80. [PMID: 16888029 DOI: 10.4049/jimmunol.177.4.2671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
52 Tangye SG, Bryant VL, Cuss AK, Good KL. BAFF, APRIL and human B cell disorders. Semin Immunol 2006;18:305-17. [PMID: 16916610 DOI: 10.1016/j.smim.2006.04.004] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 9.3] [Reference Citation Analysis]
53 Lanio N, Sarmiento E, Gallego A, Calahorra L, Jaramillo M, Navarro J, Palomo J, Fernandez-yañez J, Ruiz M, Fernandez-cruz E, Carbone J. Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients. Transpl Int 2013;26:800-12. [DOI: 10.1111/tri.12131] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
54 Zhu X, Shi Y, Peng J, Guo C, Shan N, Qin P, Ji X, Hou M. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 2009;114:5362-7. [DOI: 10.1182/blood-2009-05-217513] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
55 Coquery CM, Loo WM, Wade NS, Bederman AG, Tung KS, Lewis JE, Hess H, Erickson LD. BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity. Arthritis Rheumatol 2015;67:773-84. [PMID: 25385309 DOI: 10.1002/art.38950] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
56 Das S, Sutoh Y, Hirano M, Han Q, Li J, Cooper MD, Herrin BR. Characterization of Lamprey BAFF-like Gene: Evolutionary Implications. J Immunol 2016;197:2695-703. [PMID: 27543613 DOI: 10.4049/jimmunol.1600799] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
57 Gorbacheva V, Ayasoufi K, Fan R, Baldwin WM 3rd, Valujskikh A. B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. Am J Transplant 2015;15:346-57. [PMID: 25496308 DOI: 10.1111/ajt.12984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
58 Zhang B, Hu M, Zhang P, Cao H, Wang Y, Wang Z, Su T. BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res 2013;46:433-9. [PMID: 23681290 DOI: 10.1590/1414-431X20132665] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
59 Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945-50. [PMID: 19666484 DOI: 10.1073/pnas.0903543106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 223] [Article Influence: 19.2] [Reference Citation Analysis]
60 Hamzaoui K, Houman H, Hentati F, Hamzaoui A. BAFF is up-regulated in central nervous system of neuro-Behçet's disease. J Neuroimmunol 2008;200:111-4. [PMID: 18625522 DOI: 10.1016/j.jneuroim.2008.06.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
61 Inaba A, Clatworthy MR. Novel immunotherapeutic strategies to target alloantibody-producing B and plasma cells in transplantation: . Current Opinion in Organ Transplantation 2016;21:419-26. [DOI: 10.1097/mot.0000000000000338] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
62 Zhu X, Shi Y, Zhang F, Yao Q, Liu Y, Shan N, Wang D, Peng J, Xu J, Hou M. Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia. Br J Haematol 2014;166:783-91. [DOI: 10.1111/bjh.12958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Sutherland AP, Mackay F, Mackay CR. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas. Pharmacology & Therapeutics 2006;112:774-86. [DOI: 10.1016/j.pharmthera.2006.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
64 Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2608-18. [DOI: 10.1007/s10620-016-4136-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
65 Parackova Z, Klocperk A, Rataj M, Kayserova J, Zentsova I, Sumnik Z, Kolouskova S, Sklenarova J, Pruhova S, Obermannova B, Petruzelkova L, Lebl J, Kalina T, Sediva A. Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes. Immunol Lett 2017;189:94-100. [PMID: 28414179 DOI: 10.1016/j.imlet.2017.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
66 Wang Q, Racine JJ, Ratiu JJ, Wang S, Ettinger R, Wasserfall C, Atkinson MA, Serreze DV. Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy. J Immunol 2017;199:3757-70. [PMID: 29055002 DOI: 10.4049/jimmunol.1700822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
67 Gardam S, Brink R. Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol 2014;4:509. [PMID: 24432023 DOI: 10.3389/fimmu.2013.00509] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
68 Yu L, Zhang C, Zhang L, Shi Y, Ji X. Biomarkers for immune thrombocytopenia. Biomark Res 2015;3:19. [PMID: 26185681 DOI: 10.1186/s40364-015-0045-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
69 Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang GM, Feng ZH, Huang B. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 2008;63:327-32. [PMID: 18053009 DOI: 10.1111/j.1398-9995.2007.01566.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.0] [Reference Citation Analysis]
70 Zhang Y, Tian J, Xiao F, Zheng L, Zhu X, Wu L, Zhao C, Wang S, Rui K, Zou H, Lu L. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 2021. [DOI: 10.1016/j.cytogfr.2021.11.004] [Reference Citation Analysis]
71 Suchanek O, Clatworthy MR. Novel strategies to target the humoral alloimmune response. HLA 2020;96:667-80. [PMID: 33022883 DOI: 10.1111/tan.14092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Coquery CM, Wade NS, Loo WM, Kinchen JM, Cox KM, Jiang C, Tung KS, Erickson LD. Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice. PLoS One 2014;9:e102284. [PMID: 25010693 DOI: 10.1371/journal.pone.0102284] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
73 Tang X, Tong X, An Y. BAFF gene silencing attenuates allergic airway inflammation by promoting the generation of Tregs via activating pro-Treg cytokines. Life Sci 2020;241:117172. [PMID: 31843529 DOI: 10.1016/j.lfs.2019.117172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
74 Saito K, Mori S, Date F, Ono M. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand. Autoimmunity 2013;46:231-7. [PMID: 23301790 DOI: 10.3109/08916934.2012.757307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
75 Durand J, Chiffoleau E. B cells with regulatory properties in transplantation tolerance. World J Transplant 2015; 5(4): 196-208 [PMID: 26722647 DOI: 10.5500/wjt.v5.i4.196] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
76 Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Experimental Dermatology 2008;17:197-202. [DOI: 10.1111/j.1600-0625.2007.00642.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
77 Mariño E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 2014;44:983-93. [PMID: 24435807 DOI: 10.1002/eji.201344186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
78 Marston B, Looney RJ. Translating the effects of BAFF in SLE. Nat Rev Rheumatol 2010;6:503-4. [DOI: 10.1038/nrrheum.2010.136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
79 Sarmiento E, Jaramillo M, Calahorra L, Fernandez-Yañez J, Gomez-Sanchez M, Crespo-Leiro MG, Paniagua M, Almenar L, Cebrian M, Rabago G, Levy B, Segovia J, Gomez-Bueno M, Lopez J, Mirabet S, Navarro J, Rodriguez-Molina JJ, Fernandez-Cruz E, Carbone J. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study. J Heart Lung Transplant 2017;36:529-39. [PMID: 27866926 DOI: 10.1016/j.healun.2016.10.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
80 Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005;115:3083-92. [PMID: 16239971 DOI: 10.1172/JCI25265] [Cited by in Crossref: 179] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
81 Ali AM, DiPersio JF, Schroeder MA. The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review. Biol Blood Marrow Transplant 2016;22:1552-64. [PMID: 27158050 DOI: 10.1016/j.bbmt.2016.04.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
82 Lim JY, Park MJ, Im KI, Kim N, Park HS, Lee SH, Kim EK, Nam YS, Lee ES, Cho ML, Cho SG. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease. Exp Hematol 2015;43:23-31.e1-2. [PMID: 25246268 DOI: 10.1016/j.exphem.2014.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
83 Afzali S, Salehi S, Shahi A, Esmaeili M, Farashi Bonab S, Peykari A, Bagherpour F, Ansaripour B, Soleimanian T, Pour-Reza-Gholi F, Amirzargar A. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection. J Immunol Res 2021;2021:6654992. [PMID: 33748289 DOI: 10.1155/2021/6654992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Cancro MP. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol Rev 2004;202:237-49. [PMID: 15546397 DOI: 10.1111/j.0105-2896.2004.00212.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
85 Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44. [PMID: 15843552 DOI: 10.4049/jimmunol.174.9.5537] [Cited by in Crossref: 111] [Cited by in F6Publishing: 104] [Article Influence: 6.5] [Reference Citation Analysis]
86 Reyes LI, León F, González P, Rozas MF, Labarca C, Segovia A, Neira O, Naves R. Dexamethasone inhibits BAFF expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Cytokine 2008;42:170-8. [PMID: 18316202 DOI: 10.1016/j.cyto.2007.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
87 Tan AH, Tso GHW, Zhang B, Teo PY, Ou X, Ng SW, Wong AXF, Tan SJX, Sanny A, Kim SS, Lee AP, Xu S, Lam KP. TACI Constrains TH17 Pathogenicity and Protects against Gut Inflammation. iScience 2020;23:101707. [PMID: 33205021 DOI: 10.1016/j.isci.2020.101707] [Reference Citation Analysis]
88 Zhang H, Wang Z, Zhang J, Zhang X, Gui Z, Sun L, Yang H, Tan R, Gu M. The synergism of B and T lymphocyte attenuator (BTLA) and cytotoxic T lymphocyte associated antigen-4 (CTLA-4) attenuated acute T-cell mediated rejection and prolonged renal graft survival. Transl Androl Urol 2020;9:1990-9. [PMID: 33209663 DOI: 10.21037/tau-20-728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Banham G, Prezzi D, Harford S, Taylor CJ, Hamer R, Higgins R, Bradley JA, Clatworthy MR. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection. Transplantation. 2013;96:413-420. [PMID: 23842189 DOI: 10.1097/tp.0b013e318298dd65] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
90 Gavin AL, Duong B, Skog P, Aït-azzouzene D, Greaves DR, Scott ML, Nemazee D. ΔBAFF, a Splice Isoform of BAFF, Opposes Full-Length BAFF Activity In Vivo in Transgenic Mouse Models. J Immunol 2005;175:319-28. [DOI: 10.4049/jimmunol.175.1.319] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
91 Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5:235-246. [PMID: 16474316 DOI: 10.1038/nrd1982] [Cited by in Crossref: 224] [Cited by in F6Publishing: 210] [Article Influence: 14.0] [Reference Citation Analysis]
92 Nestorov I, Munafo A, Papasouliotis O, Visich J. Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis. J Clin Pharmacol 2008;48:406-17. [PMID: 18303125 DOI: 10.1177/0091270008315312] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
93 Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One 2008;3:e3192. [PMID: 18784835 DOI: 10.1371/journal.pone.0003192] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
94 Zhou Z, Zhou Z, Chen Z, Zhou Z, Chen Z, Li H, Chen X, Xu J, Gu D, Du W, Zheng C, Zhang L, Huang Y, Ren Q, Yang R. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity 2009;42:112-9. [DOI: 10.1080/08916930802397848] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
95 Jia X, Wei F, Sun X, Chang Y, Xu S, Yang X, Wang C, Wei W. CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4+ T cells. Journal of Ethnopharmacology 2016;189:194-201. [DOI: 10.1016/j.jep.2016.05.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
96 Shin HS, Grgic I, Chandraker A. Novel Targets of Immunosuppression in Transplantation. Clin Lab Med 2019;39:157-69. [PMID: 30709504 DOI: 10.1016/j.cll.2018.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Clatworthy MR. B cell modulation in transplantation. Clin Exp Immunol 2014;178 Suppl 1:61-3. [PMID: 25546764 DOI: 10.1111/cei.12513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
98 Jackson SW, Scharping NE, Jacobs HM, Wang S, Chait A, Rawlings DJ. Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation. J Immunol 2016;197:4529-34. [PMID: 27837104 DOI: 10.4049/jimmunol.1601198] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
99 Czaja AJ. Review article: targeting the B cell activation system in autoimmune hepatitis. Aliment Pharmacol Ther 2021;54:902-22. [PMID: 34506662 DOI: 10.1111/apt.16574] [Reference Citation Analysis]